Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury

Hagiwara, Satoshi; Iwasaka, Hideo; Noguchi, Takayuki
May 2007
Journal of Anesthesia;2007, Vol. 21 Issue 2, p164
Academic Journal
High mobility group box 1 (HMGB1) protein has recently been shown to be an important late mediator of acute lung injury and a promising therapeutic target. Nafamostat mesilate (NM) is a broad-range synthetic protease inhibitor with some anti-inflammatory action. The purpose of this study was to evaluate the effect of NM on HMGB1 in lipopolysaccharide (LPS)-induced lung injury in rats. Male Wistar rats were given either saline (LPS group) or NM (NM+LPS group) 30 min before the intravenous injection of a bolus of LPS (5 mg·kg−1). After the administration of LPS, injury to the lung and the expression of HMGB1, tumor necrosis factor-α (TNF-α), and plasminogen activator inhibitor-1 (PAI-1) were examined. Histological examination revealed that interstitial edema, leukocytic infiltration, and HMGB1 protein expression were markedly reduced in the NM+LPS group compared to the LPS group. Furthermore, the LPS-induced increases in PAI-1 activity and in plasma TNF-α concentrations were also lower in the rats given both NM and LPS than in the rats given LPS alone. The anticoagulatory activity of NM may have inhibited PAI-1, while its anti-inflammatory activity blockaded TNF-α, thereby indirectly inhibiting HMGB1 and reducing tissue damage in the lung. These findings indicate that NM can inhibit the lung injury induced by LPS in rats. NM is an excellent candidate for use in new therapeutic strategies to prevent or minimize lung injury.


Related Articles

  • α7 Nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury. Kox, M.; Pompe, J. C.; Peters, E.; Vaneker, M.; van der Laak, J. W.; van der Hoeven, J. G.; Scheffer, G. J.; Hoedemaekers, C. W.; Pickkers, P. // BJA: The British Journal of Anaesthesia;Oct2011, Vol. 107 Issue 4, p559 

    Background Mechanical ventilation (MV) induces an inflammatory response that can lead to lung injury. The vagus nerve can limit the inflammatory response through the cholinergic anti-inflammatory pathway. We evaluated the effects of stimulation of the cholinergic anti-inflammatory pathway with...

  • Wogonoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice. Zhang, Liang; Ren, Yi; Yang, Chengliang; Guo, Yue; Zhang, Xiaojing; Hou, Gang; Guo, Xinjin; Sun, Nan; Liu, Yongyu // Inflammation;Dec2014, Vol. 37 Issue 6, p2006 

    Wogonoside has been reported to have anti-inflammatory properties. In this study, we evaluated the effect of wogonoside on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. Male BALB/c mice with ALI, induced by intranasal instillation of LPS, were treated with wogonoside 1 h...

  • Efficiency and Tolerability of Artrofoon (Ultralow Doses and Antibodies to TNF-α) in Osteoarthrosis. Alikhanov, B. A.; Pavlenko, A. Yu. // Bulletin of Experimental Biology & Medicine;Sep2009, Vol. 148 Issue 3, p470 

    Antiinflammatory and analgesic effects of artrofoon in osteoarthritis and the absence of side effects were demonstrated. The maximum antiinflammatory effect was attained by the end of the 3rd month of artrofoon treatment. The effect persisted from 6 months to 2 years against the background of...

  • Etanercept.  // Reactions Weekly;10/15/2005, Issue 1073, p10 

    Discusses a case report on a 37-year-old man who developed lung injury during treatment with etanercept, a tumor necrosis factor-alpha receptor, for psoriatic arthritis. Reference to a study by K. Phillips et al which appeared in the August 2005 issue of "Arthritis Care and Research";...

  • The Effects of Morin on Lipopolysaccharide-Induced Acute Lung Injury by Suppressing the Lung NLRP3 Inflammasome. Tianzhu, Zhang; Shihai, Yang; Juan, Du // Inflammation;Dec2014, Vol. 37 Issue 6, p1976 

    In previous study, the anti-inflammatory effect of morin had been found. In this study, we investigated anti-inflammatory effects of morin on acute lung injury using lipopolysaccharide (LPS)-induced acute lung injury (ALI) mouse model. The cell counting in the bronchoalveolar lavage fluid (BALF)...

  • Stevioside Protects LPS-Induced Acute Lung Injury in Mice. Yingkun, Nie; Zhenyu, Wang; Jing, Lin; Xiuyun, Lu; Huimin, Yu // Inflammation;Feb2013, Vol. 36 Issue 1, p242 

    Stevioside, a diterpene glycoside component of Stevia rebaudiana, has been known to exhibit anti-inflammatory properties. To evaluate the effect and the possible mechanism of stevioside in lipopolysaccharide (LPS)-induced acute lung injury, male BALB/c mice were pretreated with stevioside or...

  • Effects of a Natural Prolyl Oligopeptidase Inhibitor, Rosmarinic Acid, on Lipopolysaccharide-Induced Acute Lung Injury in Mice. Xiao Chu; Xinxin Ci; Jiakang He; Lanxiang Jiang; Miaomiao Wei; Qingjun Cao; Mingfeng Guan; Xianxing Xie; Xuming Deng // Molecules;Mar2012, Vol. 17 Issue 3, p3586 

    Rosmarinic acid (RA), a polyphenolic phytochemical, is a natural prolyl oligopeptidase inhibitor. In the present study, we found that RA exerted potent anti-inflammatory effects in in vivo models of acute lung injury (ALI) induced by lipopolysaccharide (LPS). Mice were pretreated with RA one...

  • Is There an Increased Risk of Lymphoma and Malignancies Under Anti-TNF Therapy in IBD? Lakatos, P. L.; Miheller, P. // Current Drug Targets;Feb2010, Vol. 11 Issue 2, p179 

    Tumour necrosis factor alpha (TNF-alpha) inhibitors ensure valuable treatment advantages for patients with inflammatory bowel diseases (IBD) by offering a more targeted anti-inflammatory therapy. In contrast, there is concern that it might increase the risk of long-term complications including...

  • OPTIMIZAREA TRATAMENTULUI ÃŽN SPONDILITA ANCHILOZANTÄ‚. Nițu, Marius Cristian; Mitulescu, Traian Costin; Predețeanu, Denisa // Romanian Journal of Rheumatology;2012, Vol. 21 Issue 3, p155 

    Patients with ankylosing spondylitis (AS) may develop in some cases a severe and aggressive form of disease. The treatment for AS has been a challenge for practitioners for a very long time, based only on non-steroid anti-inflammatory drugs (NSAIDs) and physical therapy; the introduction of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics